-
Mylan Price Target Slashed Even As TLD Drug Receives Tentative Approval
Monday, August 7, 2017 - 11:56am | 505Morgan Stanley reduced its price target on the shares of Mylan N.V. (NASDAQ: MYL) following downward revision to its estimates due to the IMS trends, generic price pressure and uncertain new launch timing. Meanwhile, in a separate note, Mylan announced its NDA for TLD, a combo of Lamivudhine...
-
The Web's Most Dangerous Domains
Sunday, September 6, 2015 - 11:39am | 393Earlier this week, security firm Blue Coat Systems Inc released a list of the 10 most dangerous web domains. Although the list has drawn some high-profile objections, Blue Coat claims that more than 95 percent of the sites on these 10 Top Level Domains (TLDs) are suspicious. What Is A TLD?...